Ticker
PHATCompany Name
PHATHOM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 250.22M | $ 152.43M | 60.92% |
3/31/2025 | $ 294.21M | $ 215.18M | 73.14% |
12/31/2024 | $ 378.32M | $ 300.13M | 79.33% |
9/30/2024 | $ 387.04M | $ 337.54M | 87.21% |
6/30/2024 | $ 319.38M | $ 279.1M | 87.39% |
3/31/2024 | $ 356.5M | $ 325.1M | 91.19% |
12/31/2023 | $ 413.84M | $ 384.26M | 92.85% |
9/30/2023 | $ 236.99M | $ 216.53M | 91.37% |
6/30/2023 | $ 265.04M | $ 249.38M | 94.09% |
3/31/2023 | $ 144.01M | $ 130.08M | 90.33% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PHATHOM PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 226.36M ] / Assets [ $ 230.89M ]
(=) Cash to Assets [ 98.04% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |